Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Cannara Biotech ( (TSE:LOVE) ) is now available.
Cannara Biotech reported record first-quarter fiscal 2026 results, with total revenues of $30.1 million, gross profit before fair value adjustments of $13.5 million representing a 45% margin, and adjusted EBITDA of $8.8 million, supported by $8.0 million in operating cash flow and $3.3 million in free cash flow. The company continued to gain traction nationally, lifting its estimated Canadian retail market share to 4.1% from 3.8% in the previous quarter, achieving a #1 position in Québec by December 2025 after a successful vape launch and posting ongoing growth in Ontario. Management highlighted that higher production volumes, improved yields and optimization in cultivation and post‑processing drove a double‑digit increase in gross cannabis revenues, gross profit and adjusted EBITDA versus the prior year period, and said that current investments in a new Valleyfield processing center and three additional grow zones are on budget and on schedule, positioning Cannara to expand post‑processing capacity, enhance margins and support disciplined, long‑term growth.
The most recent analyst rating on (TSE:LOVE) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Cannara Biotech stock, see the TSE:LOVE Stock Forecast page.
Spark’s Take on TSE:LOVE Stock
According to Spark, TipRanks’ AI Analyst, TSE:LOVE is a Outperform.
Cannara Biotech’s strong financial performance and positive corporate events are the most significant factors driving the score. Technical analysis and valuation are neutral, indicating a balanced outlook. The absence of earnings call data does not impact the overall score.
To see Spark’s full report on TSE:LOVE stock, click here.
More about Cannara Biotech
Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products at affordable prices, operating two large-scale cultivation and processing facilities in Québec totaling over 1.6 million square feet. The company focuses on the Canadian recreational cannabis market, with particular strength in key provinces such as Québec and Ontario, and distributes a portfolio of branded cannabis products across the country.
YTD Price Performance: 10.34%
Average Trading Volume: 48,280
Technical Sentiment Signal: Buy
Current Market Cap: C$182.2M
Learn more about LOVE stock on TipRanks’ Stock Analysis page.